Home » Topics » Regulatory » Patents

Patents
RSS

Regeneron claims novel use for neurotrophic factor

Dec. 23, 1996

Mercian discovers other anthracycline antineoplastic agents

Dec. 20, 1996

Fujisawa synthesizes novel bone resorption inhibitors

Dec. 20, 1996

Grelan, Fournier collaborate on ACAT inhibitors

Dec. 20, 1996

Tetracycline antibacterial agents under study at Pfizer

Dec. 20, 1996

Schering-Plough reveals new NK antagonists

Dec. 20, 1996

Dual NEP/ACE inhibitors claimed by Eisai

Dec. 20, 1996

Antineoplastic anthracycline antibiotic disclosed by Mercian

Dec. 19, 1996

Mercian reports new antitumor anthracycline

Dec. 19, 1996

Radiopharmaceutical agents from CIS Bio International

Dec. 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...